|

PTC THERAPEUTICS INC (PTCT)

US69366J2006 - Common Stock

26.39  +0.11 (+0.42%)

After market: 26.39 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
798.20M698.80M538.60M380.80M307.00M
Cost Of Goods
47.20M44.70M32.30M18.90M12.10M
Gross Profit
750.90M654.10M506.30M361.80M294.80M
Operating Expenses
1.15B1.07B880.70M783.00M536.00M
Research and Development
733.90M651.50M540.70M477.60M257.50M
Selling, General, and Administrative Expenses
348.90M326.00M285.80M245.20M202.50M
Operating Income
-394.40M-414.00M-374.40M-421.20M-241.20M
Interest Income/Expense
-125.00M-109.60M-100.40M-56.40M-12.50M
Other Income/Expense
41.90M-30.50M-43.50M85.20M13.70M
Non Recurring Items
N/A-33.40M0.00-10.60MN/A
Income Before Taxes
-728.80M-587.50M-518.30M-402.90M-239.90M
Income Tax
-87.00M-28.50M5.60M35.20M11.70M
Net Income
-641.80M-559.00M-523.90M-438.20M-251.60M
EBITDA
-199.64M-285.16M-310.27M-377.71M-209.02M
 
Per Share Data
EPS Diluted Total Ops
-8.65-7.79-7.43-6.64-4.27
Non GAAP EPS
-8.19-7.33-7.43-6.54-4.47
 
Statistics
Gross Profit Margin
94.07%93.60%94.00%95.01%96.03%
Profit Margin
-80.41%-79.99%-97.27%-115.07%-81.95%
Operating Profit Margin
-49.41%-59.24%-69.51%-110.61%-78.57%

All data in USD

Charts